Roundtable Discussion: Enhancing Allogeneic Cell Therapy Success by Optimizing Donor Selection Early in Development
Time: 10:00 am
day: Conference Day Two
Details:
- Exploring how early collaboration between R&D and manufacturing enhances donor selection and long-term success
- Understanding which donor characterization methods drive consistency, efficiency, and clinical readiness
- Reducing downstream risks by integrating strategic donor profiling early in development timelines
